Artificial Intelligence in Inflammatory Bowel Disease Endoscopy: Implications for Clinical Trials.

"Conflict of Interest HAA and JBC are employees of Bristol Myers Squibb. JEE reports personal fees from Boston Scientific, Falk, Lumendi, Paion, and Satisfai Health, outside the submitted work; in addition, JEE has a patent Methods and framework for assessing image quality issued, and a patent Quantification of Barrett’s oesophagus issued. RP reports personal fees from Abbott, AbbVie, Alimentiv [formerly Robarts], Amgen, Arena Pharmaceuticals, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Celltrion, Cosmos Pharmaceuticals, Eisai, Elan, Lilly, Ferring, Fresenius Kabi, Galapagos, Genentech, Gilead Sciences, GlaxoSmithKline, HC3 Communications, Janssen, Meducom, Merck, Mylan, Oppilan, Organon, Pandion Pharma, Pfizer, Progenity, Protagonist Therapeutics, Receptos, Roche, Sandoz, Satisfai Health, Schering-Plough, Shire, Sublimity Therapeutics, Takeda, Theravance Biopharma, Trellus Health, and UCB. ST has served as a paid consultant to AbbVie, Allergan, Amgen, Asahi, Bioclinica, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, ChemoCentryx, Cosmo, Enterome, Equillium, Ferring, GSK, Genentech, Genzyme, Giuliani SpA, Immunocore, Immunometabolism, Janssen, Lilly, MSD, Merck, Mestag, Neovacs, Novo Nordisk, NPS Pharmaceuticals, Pfizer, Proximagen, Receptos, Roche, Satisfai Health, Sensyne Health, Shire, Sigmoid Pharma, Sorriso, Takeda, Topivert, UCB, VHsquared, Vifor, and Zeria; he has received grants and/or has grants pending from AbbVie, ECCO, Helmsley Trust, IOIBD, Janssen, Lilly, Norman Collisson Foundation, Pfizer, UCB, UKIERI, and Vifor; he has received honoraria from AbbVie, Amgen, Biogen, Ferring, Lilly, Pfizer, and Takeda; and he has had travel/accommodation expenses covered or reimbursed by AbbVie, Amgen, Biogen, Ferring, Lilly, Johnson & Johnson, Pfizer, and Takeda. KU was an employee of Bristol Myers Squibb at the time of manuscript initiation; he reports personal fees from Arena, Bristol Myers Squibb, Crinetics Pharmaceuticals, Insmed, and Locust Walk Capital. MFB is CEO and Founder of Satisfai Health."

"Funding No funding or grant was received."